Merck & Co Inc (MRK) Common Stock USD0.50

Sell:$84.78Buy:$84.79$0.68 (0.81%)

Dow Jones:0.52%
Market closed |
Prices delayed by at least 15 minutes
Sell:$84.78
Buy:$84.79
Change:$0.68 (0.81%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:$84.78
Buy:$84.79
Change:$0.68 (0.81%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Key people

Robert M. Davis
Chairman of the Board, President, Chief Executive Officer
Caroline A Litchfield
Chief Financial Officer, Executive Vice President
Betty D. Larson
Chief Human Resources Officer, Executive Vice President
David M. Williams
Executive Vice President, Chief Information and Digital Officer
Jennifer L. Zachary
Executive Vice President, General Counsel
Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Richard R. Deluca
Executive Vice President, President - Merck Animal Health
Cristal N. Downing
Executive Vice President, Chief Communications and Public Affairs Officer
Dean Y. Li
Executive Vice President, President - Merck Research Laboratories
Dalton E. Smart
Senior Vice President Finance – Global Controller
Thomas Henry Glocer
Lead Independent Director
Douglas M. Baker
Independent Director
Mary Ellen Coe
Independent Director
Pamela J. Craig
Independent Director
Surendralal L. Karsanbhai
Independent Director
Click to see more

Key facts

  • EPIC
    MRK
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US58933Y1055
  • Market cap
    $210.09bn
  • Employees
    75,000
  • Shares in issue
    3.57bn
  • Exchange
    New York Stock Exchange
  • Index
    Dow Industry, S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.